Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18788964 | 1.00 | ALDH1A1 (0.33) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL24831153 | 0.78 | ALDH1A1 (0.33) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL18789464 | 0.69 | ALOX15 (0.41) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL24245829 | 0.68 | ALDH1A1 (0.33) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL21064733 | 0.68 | ALDH1A1 (0.33) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL18138229 | 0.68 | ALOX15 (0.37) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL18776609 | 0.68 | ALOX15 (0.37) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL26022514 | 0.66 | ALOX15 (0.41) | ALDH1A1LMNATHRBALOX15MAPK1 | |
| SCHEMBL10086112 | 0.66 | — | — | |
| SCHEMBL24245769 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | SYMRISE AG (DE) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114299-A1 | New mixtures having (4aR,5R,7aS,9R)-octahydro-2,2,5,8,8,9a-hexamethyl-4H-4a,9-methanoazuleno(5,6-d)-1,3-dioxole)(Ambrocenide®) | OR51E2, OR10J3, TAS2R7 | ALDH1A1 378/4885LMNA 3901/4885THRB 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.